Literature DB >> 1836275

B lymphocyte fibronectin receptors: expression and utilization.

D G Stupack1, S Stewart, W G Carter, E A Wayner, J A Wilkins.   

Abstract

Lymphocytes adhere to fibronectin (FN) via multiple receptors of the VLA (beta 1, CD29 integrin) family. The cellular requirement for the variety of FN receptors (FNR) which have been described is unclear, but they may be associated with differential signalling processes, cooperative effects which may stabilize cellular attachment, or cell homing and retention processes. The present study was undertaken to examine the FN adherence properties and receptor utilization patterns of human B cells. Of ten B-cell culture lines which were studied, six demonstrated a significant adherence to FN. Among these, four employed alpha 4 beta 1, (CD49d/29) and two employed alpha 4 beta 1/alpha 5 beta 1, (CD49d/29, CD49e/29). There was no apparent correlation between the differentiation status of the lines and their FNR utilization patterns. Furthermore, expression of FNR alone was not sufficient to confer FN binding potential. Freshly isolated tonsil B cells did not display significant adherence to FN. Following stimulation, a marked increase in VLA antigens was observed, and the capacity to attach to FN-coated surfaces was co-acquired. Analysis of the induced bulk B-cell population demonstrated that both alpha 4 beta 1 and alpha 5 beta 1 were used for adherence. These results clearly indicate that activated B cells, similar to T cells, may express and utilize alpha 5 beta 1 as a FNR.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836275     DOI: 10.1111/j.1365-3083.1991.tb01601.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Localization of beta 1 integrins and their extracellular ligands in human lymphoid tissues.

Authors:  T K van den Berg; M van der Ende; E A Döpp; G Kraal; C D Dijkstra
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

2.  Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus.

Authors:  Sara M O'Rourke; Becky Schweighardt; Pham Phung; Dora P A J Fonseca; Karianne Terry; Terri Wrin; Faruk Sinangil; Phillip W Berman
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner.

Authors:  Luisa F Jiménez-Soto; Stefan Kutter; Xaver Sewald; Claudia Ertl; Evelyn Weiss; Ulrike Kapp; Manfred Rohde; Torsten Pirch; Kirsten Jung; S Francesco Retta; Laurent Terradot; Wolfgang Fischer; Rainer Haas
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

4.  Galectin-8 promotes cytoskeletal rearrangement in trabecular meshwork cells through activation of Rho signaling.

Authors:  Shiri Diskin; Wei-Sheng Chen; Zhiyi Cao; Smita Gyawali; Haiyan Gong; Andrea Soza; Alfonso González; Noorjahan Panjwani
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

5.  Monoclonal antibodies to the V2 domain of MN-rgp120: fine mapping of epitopes and inhibition of α4β7 binding.

Authors:  Gerald R Nakamura; Dora P A J Fonseca; Sara M O'Rourke; Aaron L Vollrath; Phillip W Berman
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

6.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Authors:  V M Weaver; O W Petersen; F Wang; C A Larabell; P Briand; C Damsky; M J Bissell
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

7.  CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells.

Authors:  S Nishimura; Y S Chung; M Yashiro; T Inoue; M Sowa
Journal:  Jpn J Cancer Res       Date:  1996-12

8.  Activation of the alpha 4 beta 1 integrin through the beta 1 subunit induces recognition of the RGDS sequence in fibronectin.

Authors:  P Sánchez-Aparicio; C Dominguez-Jiménez; A Garcia-Pardo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.